SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioDelivery Sciences International Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone